Synthesis and anticancer activity of 2-amino-8-chloro-5,5-dioxo[1,2,4]triazolo[2,3-b][1,4,2]benzodithiazine derivatives

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 7, 2003, Pages 1259-1267

  Pomarnacka, Elzbieta ^a   Gdaniec, Maria ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2 (3,5 DIMETHOXYPHENYLAMINO) 7 METHYL 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE; 8 CHLORO 2 (3,5 DIMETHYLPHENYLAMINO) 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBONITRILE; 8 CHLORO 2 (3,5 DIMETHYLPHENYLAMINO) 7 METHYL 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE; 8 CHLORO 2 (4 CHLOROPHENYLAMINO) 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBONITRILE; 8 CHLORO 2 (4 CHLOROPHENYLAMINO) 7 METHYL 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE; 8 CHLORO 2 (4 METHYLPHENYLAMINO) 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBONITRILE; 8 CHLORO 2 PHENYLAMINO 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBONITRILE; 8 CHLORO 7 METHYL 2 (4 METHYLPHENYLAMINO) 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE; 8 CHLORO 7 METHYL 2 PHENYLAMINO 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE; METHYL 8 CHLORO 2 (3,5 DIMETHOXYPHENYLAMINO) 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBOXYLATE; METHYL 8 CHLORO 2 (3,5 DIMETHYLPHENYLAMINO) 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBOXYLATE; METHYL 8 CHLORO 2 (4 METHYLPHENYLAMINO) 5,5 DIOXO 1,2,4 [1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBOXYLATE; METHYL 8 CHLORO 2 PHENYLAMINO 5,5 DIOXO[1,2,4]TRIAZOLO[2,3 B][1,4,2]BENZODITHIAZINE 7 CARBOXYLATE; THIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TUMOR CELL LINE; X RAY ANALYSIS;

EID: 0037375849     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00638-7     Document Type: Article

References (28)

1. Pikul S., Ohler N.E., Ciszewski G., Lauferweiler M.C., Almstead N.G., Natchus M.G., Hsieh L.C., Janusz M.J., Peng S.X., Branch T.M., King S.L., Taiwo Y.O., Mieling G.E. J. Med. Chem. 44:2001;2499.
2. Wada C.K., Holms J.H., Cutin M.L., Dai Y., Florjancic A.S., Garland R.B., Guo Y., Heyman H.R., Stacey J.R. J. Med. Chem. 45:2002;219.
3. Scozzafava A., Menabuoni L., Mincione F., Supuran C.T. J. Med. Chem. 45:2002;1466.
4. Owa T., Yoshino H., Okauchi T., Yoshimatsu K., Ozawa Y., Nagasu T., Koyanagi N., Kitoh K. J. Med. Chem. 42:1999;3789.
5. Casini A., Scozzafava A., Mastrolorenzo A., Supuran C.T. Curr. Cancer Drug Targets. 2:2002;55.
6. Brzozowski Z. Acta Pol. Pharm. Drug Res. 52:1995;91.
7. Brzozowski Z. Acta Pol. Pharm. Drug Res. 52:1995;287.
8. Brzozowski Z. Acta Pol. Pharm. Drug Res. 53:1996;269.
9. Pomarnacka E. Acta Pol. Pharm. Drug Res. 53:1996;373.
10. Pomarnacka E., Brzozowski Z. Acta Pol. Pharm. Drug Res. 54:1997;215.
11. Pomarnacka E., Kornicka A. Farmaco. 56:2001;571.
12. Brzozowski Z., Sacedil;czewski F. Eur. J. Med. Chem. 37:2002;285.
13. Pomarnacka E., Kornicka A., Sa̧czewski F. Heterocycles. 55:2001;753.
14. Neamati N., Mazumder A., Owen J.M., Schultz R.J., Sunder S., Pommier Y. Antiviral Chem. Chemother. 8:1997;485.
15. Brzozowski Z. Acta Polon. Pharm. Drug Res. 55:1998;49.
16. Brzozowski Z. Acta Pol. Pharm. Drug Res. 55:1998;473.
17. Pomarnacka E. Acta Pol. Pharm. Drug Res. 55:1998;481.
18. Brzozowski Z. Acta Pol. Pharm. Drug Res. 54:1997;293.
19. Brzozowski Z., Sa̧czewski F. J. Med. Chem. 45:2002;430.
20. Pandeya S.N., Smitha S., Stables J.P. Arch. Pharm. Med. Chem. 4:2002;133.
21. Katritzky A.R., Ji Fu-Bao, Fan Wei-Qiang, Gallos J.K., Greenhill J.V., King R.W., Steel P.J. J. Org. Chem. 57:1992;190.
22. Engels J., Krahmer U., Zsolnai L., Hutter G. Liebigs Ann. Chem. 1992;745.
23. Kuroda R., Sanderson M.R., Neidle S., Reese C.B. J. Chem. Soc., Perkin Trans. 2. 1982;617.
24. Boyd M.R. Princ. Pract. Oncol. 3:1989;1.
25. Monks A.P., Scudiero D.A., Skehan P., Shoemaker K.D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J., Boyd M.J. Natl. Cancer Inst. 83:1991;757.
26. Brzozowski Z., Gajewski F., Sławiński J., Pomarnacka E. Acta Pol. Pharm. Drug Res. 50:1993;199.
27. Brzozowski Z., Sławiński J. Acta Pol. Pharm. 41:1984;133.
28. Brzozowski Z., Sławiński J. Acta Pol. Pharm. 41:1984;5.